Cargando…
Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer
Chimeric antigen receptor (CAR) T-cell therapy represents a new genetically engineered method of immunotherapy for cancer. The patient’s T-cells are modified to express a specific receptor that sticks to the tumor antigen. This modified cell is then reintroduced into the patient’s body to fight the...
Autores principales: | Sur, Daniel, Havasi, Andrei, Cainap, Calin, Samasca, Gabriel, Burz, Claudia, Balacescu, Ovidiu, Lupan, Iulia, Deleanu, Diana, Irimie, Alexandru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019711/ https://www.ncbi.nlm.nih.gov/pubmed/31936611 http://dx.doi.org/10.3390/jcm9010182 |
Ejemplares similares
-
Predictive Efficacy of MiR-125b-5p, MiR-17-5p, and MiR-185-5p in Liver Metastasis and Chemotherapy Response Among Advanced Stage Colorectal Cancer Patients
por: Sur, Daniel, et al.
Publicado: (2021) -
Gluten-free diet and quality of life in celiac disease
por: Samasca, Gabriel, et al.
Publicado: (2014) -
Is it necessary to screen Helicobacter pylori infection in patients with celiac disease and iron deficiency?
por: Samasca, Gabriel, et al.
Publicado: (2016) -
Celiac disease as an autoimmune condition
por: Samasca, Gabriel, et al.
Publicado: (2014) -
Circulating tumor cells in clinical research and monitoring patients with colorectal cancer
por: Burz, Claudia, et al.
Publicado: (2018)